Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Defining insulin resistance from hyperinsulinemic-euglycemic clamps.

Tam CS, Xie W, Johnson WD, Cefalu WT, Redman LM, Ravussin E.

Diabetes Care. 2012 Jul;35(7):1605-10. doi: 10.2337/dc11-2339. Epub 2012 Apr 17.

2.

Insulin resistance in obesity can be reliably identified from fasting plasma insulin.

ter Horst KW, Gilijamse PW, Koopman KE, de Weijer BA, Brands M, Kootte RS, Romijn JA, Ackermans MT, Nieuwdorp M, Soeters MR, Serlie MJ.

Int J Obes (Lond). 2015 Dec;39(12):1703-9. doi: 10.1038/ijo.2015.125. Epub 2015 Jul 9.

PMID:
26155920
3.

Limitations of fasting indices in the measurement of insulin sensitivity in Afro-Caribbean adults.

Thompson DS, Boyne MS, Osmond C, Ferguson TS, Tulloch-Reid MK, Wilks RJ, Barnett AT, Forrester TE.

BMC Res Notes. 2014 Feb 20;7:98. doi: 10.1186/1756-0500-7-98.

4.

Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states.

Rabasa-Lhoret R, Bastard JP, Jan V, Ducluzeau PH, Andreelli F, Guebre F, Bruzeau J, Louche-Pellissier C, MaItrepierre C, Peyrat J, Chagné J, Vidal H, Laville M.

J Clin Endocrinol Metab. 2003 Oct;88(10):4917-23.

PMID:
14557474
5.

The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese.

Syvertsen C, Halse J, Høivik HO, Gaullier JM, Nurminiemi M, Kristiansen K, Einerhand A, O'Shea M, Gudmundsen O.

Int J Obes (Lond). 2007 Jul;31(7):1148-54. Epub 2006 Oct 10.

PMID:
17031391
6.
7.

Acute effect of roux-en-y gastric bypass on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clamp.

Lima MM, Pareja JC, Alegre SM, Geloneze SR, Kahn SE, Astiarraga BD, Chaim EA, Geloneze B.

J Clin Endocrinol Metab. 2010 Aug;95(8):3871-5. doi: 10.1210/jc.2010-0085. Epub 2010 May 19.

PMID:
20484482
8.

[13C]glucose breath testing provides a noninvasive measure of insulin resistance: calibration analyses against clamp studies.

Hussain M, Jangorbhani M, Schuette S, Considine RV, Chisholm RL, Mather KJ.

Diabetes Technol Ther. 2014 Feb;16(2):102-12. doi: 10.1089/dia.2013.0151. Epub 2013 Oct 11.

9.

Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children.

Uwaifo GI, Fallon EM, Chin J, Elberg J, Parikh SJ, Yanovski JA.

Diabetes Care. 2002 Nov;25(11):2081-7.

PMID:
12401760
10.

Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistance.

Shalaurova I, Connelly MA, Garvey WT, Otvos JD.

Metab Syndr Relat Disord. 2014 Oct;12(8):422-9. doi: 10.1089/met.2014.0050. Epub 2014 Jun 24.

11.

Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load.

Derosa G, Cicero AF, Fogari E, D'Angelo A, Bonaventura A, Romano D, Maffioli P.

J Clin Lipidol. 2012 Nov-Dec;6(6):553-64. doi: 10.1016/j.jacl.2012.02.010. Epub 2012 Feb 27.

PMID:
23312051
12.

[Application of extended hyperinsulinemic euglycemic clamp in the assessment of insulin sensitivity in obese individuals with glucose intolerance].

Bao YQ, Jia WP, Chen L, Lu JX, Zhu M, Lu W, Xiang KA.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Dec;28(6):740-4. Chinese.

13.

Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea.

Kang ES, Yun YS, Park SW, Kim HJ, Ahn CW, Song YD, Cha BS, Lim SK, Kim KR, Lee HC.

Metabolism. 2005 Feb;54(2):206-11.

PMID:
15690315
14.

Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia.

Liao Y, Kwon S, Shaughnessy S, Wallace P, Hutto A, Jenkins AJ, Klein RL, Garvey WT.

Diabetes Care. 2004 Apr;27(4):978-83.

PMID:
15047659
15.

Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.

Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.

Diabetes. 2000 Jul;49(7):1209-18.

PMID:
10909980
16.

Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients.

Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M, Tahara H, Shoji T, Okuno Y, Nishizawa Y.

Diabetes Care. 2003 Aug;26(8):2426-32.

PMID:
12882874
17.

Identification of individuals with insulin resistance using routine clinical measurements.

Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP.

Diabetes. 2005 Feb;54(2):333-9.

18.

Evaluation of insulin sensitivity in hyperprolactinemic subjects by euglycemic hyperinsulinemic clamp technique.

Tuzcu A, Yalaki S, Arikan S, Gokalp D, Bahcec M, Tuzcu S.

Pituitary. 2009;12(4):330-4. doi: 10.1007/s11102-009-0183-1. Epub 2009 May 1.

PMID:
19408128
19.

Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension.

Lansang MC, Williams GH, Carroll JS.

Am J Hypertens. 2001 Jan;14(1):51-3.

PMID:
11206679
20.

Hyperinsulinemic-euglycemic clamp to assess insulin sensitivity in vivo.

Kim JK.

Methods Mol Biol. 2009;560:221-38. doi: 10.1007/978-1-59745-448-3_15.

PMID:
19504253

Supplemental Content

Support Center